Bone metastases

• Published in: Anales del sistema sanitario de Navarra Vol. 29; no. 2; pp. 177 - 188
• Main Authors: Vicent, S, Luis-Ravelo, D, Antón, I, Hernández, I, Martínez, S, de las Rivas, J, Gúrpide, A, Lecanda, F
• Format: Journal Article
• Language: Spanish
• Published: Spain 01.05.2006
• Subjects: Biomedical Research - trends; Bone Neoplasms - secondary; Bone Neoplasms - therapy; Forecasting; Humans
• ISSN: 1137-6627

Bone metastases represent a devastating clinical problem in the most frequent neoplasies, especially in multiple myeloma, tumours breast, prostate and lung. The consequences include pain which is refractory to conventional analgesics, osteolysis often leading to bone-marrow compression and pathological fractures, and metabolic disorders. Recent advances in diagnosis using imaging techniques as well as different biochemical techniques have helped accurate diagnosis and follow-up. The increase in survival has improved through a multimodal approach combining, inhibition of osteolysis, with prophylactic orthopaedic surgery and radiation therapy. Recent advances in basic research have determined the molecular metastatic that can predict its proclivity to metastasize. Basic research will improve understanding of the basic mechanisms and lead to the clarification of molecular targets that will help in the development of medicines capable of preventing, decreasing or blocking the metastatic process.